ProPhase Labs, Inc. Deferred Income Taxes and Tax Credits
ProPhase Labs, Inc. (PRPH) reported Deferred Income Taxes and Tax Credits of -$307.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxesAndTaxCredits · last filed 2023-11-13
- ProPhase Labs, Inc. deferred income taxes and tax credits for the quarter ending 2023-09-30 was $0.00.
- ProPhase Labs, Inc. deferred income taxes and tax credits for the quarter ending 2023-06-30 was -$307.00K.
- ProPhase Labs, Inc. deferred income taxes and tax credits for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- ProPhase Labs, Inc. deferred income taxes and tax credits for the quarter ending 2022-09-30 was $0.00.
| Period end | Deferred Income Taxes and Tax Credits 3 month | Deferred Income Taxes and Tax Credits 6 month | Deferred Income Taxes and Tax Credits 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$307.00K derived: sum of 2 quarters · filed 2023-11-13 | -$307.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$307.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$307.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$443.00K derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 |
| 2022-06-30 | -$443.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | |
| 2022-03-31 | $443.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |